Tricyclic thromboxane A.sub.2 antagonists
US5302602A · kind A · utility
19Cited by
7References
10Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | May 18, 1992 |
| Grant date | Apr 12, 1994 |
| Priority date | — |
| Expiry date | May 18, 2012 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07D471/10
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
Novel tricyclic compounds having a TXA.sub.2 antagonizing activity represented by formula (I): ##STR1## possess a potent antagonizing against thromboxane A.sub.2 and also an antiallergic and/or antihistaminic activity, and are expected to have preventive and therapeutic effects on ischemic diseases, cerebro-vascular diseases, etc.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.